Ear-Zapping device aims to keep opioid users on track

NCT ID NCT06130501

Completed Disease control Sponsor: University of Cincinnati Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests a small ear device that gently stimulates nerves to see if it helps people with both PTSD and opioid use disorder stay on buprenorphine therapy. Twenty participants will use either the active device or a placebo for 12 weeks. Researchers will check if they keep their buprenorphine prescription and how well they tolerate the device.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sparrow Ascent device (transcutaneous auricular neurostimulation)
What this could lead to: If it works, this could offer a drug-free way to help people with PTSD and opioid use disorder stick with buprenorphine therapy, improving recovery chances.
What could go wrong: This is a very small early study with only 20 people, so results may not apply widely. The device may be no better than a placebo, and some may find it uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER POSTTRAUMATIC STRESS DISORDER

Contacts and locations

Locations

Gibson Center for Behavioral Change

Cape Girardeau, Missouri, 63703, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.